| 臺大學術典藏 |
2021-02-02T00:46:09Z |
MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells
|
Lin S.-R.;Yeh H.-C.;Wang W.-J.;Ke H.-L.;Lin H.-H.;Hsu W.-C.;Chao S.-Y.;Hour T.-C.;Wu W.-J.;Yeong-Shiau Pu;Huang A.-M.; Lin S.-R.; Yeh H.-C.; Wang W.-J.; Ke H.-L.; Lin H.-H.; Hsu W.-C.; Chao S.-Y.; Hour T.-C.; Wu W.-J.; YEONG-SHIAU PU; Huang A.-M. |
| 臺大學術典藏 |
2021-02-02T00:43:44Z |
Importance of urodynamic study before radical hysterectomy for cervical cancer
|
Lin H.-H.;Hong-Jeng Yu;Sheu B.-C.;Huang S.-C.; Lin H.-H.; HONG-JENG YU; Sheu B.-C.; Huang S.-C. |
| 臺大學術典藏 |
2021-02-02T00:43:17Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Lin H.-H.;Liu S.-P.;Huang K.-H.;Hong-Jeng Yu; Ho C.-H.; Chang T.-C.; Lin H.-H.; Liu S.-P.; Huang K.-H.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:15Z |
Comparison of overall sexual function, sexual intercourse/activity, sexual satisfaction, and sexual desire during the three trimesters of pregnancy and assessment of their determinants
|
Chang S.-R.; Chen K.-H.; Lin H.-H.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:14Z |
Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome
|
Hsiao S.-M.; Chang T.-C.; Wu W.-Y.; Chen C.-H.; HONG-JENG YU; Lin H.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010
|
Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo H.-C.;Lin H.-H.;Hong-Jeng Yu;Cheng C.-L.;Hung M.-J.;Lin A.T.L.; Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L. |
| 臺大學術典藏 |
2021-02-01T02:11:08Z |
Mortality, morbidity, and risk factors in Taiwan, 1990–2017: findings from the Global Burden of Disease Study 2017
|
Wu Y.-C.;Lo W.-C.;Lu T.-H.;Shu-Sen Chang;Lin H.-H.;Chan C.-C.; Wu Y.-C.; Lo W.-C.; Lu T.-H.; SHU-SEN CHANG; Lin H.-H.; Chan C.-C. |
| 臺大學術典藏 |
2021-01-29T03:17:30Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Lin H.-H.;Shih-Ping Liu;Huang K.-H.;Yu H.-J.; Ho C.-H.; Chang T.-C.; Lin H.-H.; SHIH-PING LIU; Huang K.-H.; Yu H.-J. |
| 臺大學術典藏 |
2021-01-28T02:03:41Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Lin H.-H.;Liu S.-P.;Kuo-How Huang;Yu H.-J.; Ho C.-H.; Chang T.-C.; Lin H.-H.; Liu S.-P.; KUO-HOW HUANG; Yu H.-J. |
| 臺大學術典藏 |
2021-01-26T03:36:46Z |
The Kunitz Domain i of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells
|
Wu S.-R.;Teng C.-H.;Tu Y.-T.;Ko C.-J.;Cheng T.-S.;Lan S.-W.;Lin H.-Y.;Lin H.-H.;Tu H.-F.;Hsiao P.-W.;Huang H.-P.;Chung-Hsin Chen;Lee M.-S.; Wu S.-R.; Teng C.-H.; Tu Y.-T.; Ko C.-J.; Cheng T.-S.; Lan S.-W.; Lin H.-Y.; Lin H.-H.; Tu H.-F.; Hsiao P.-W.; Huang H.-P.; CHUNG-HSIN CHEN; Lee M.-S. |
| 臺大學術典藏 |
2021-01-26T03:36:46Z |
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis
|
Ko C.-J.;Lan S.-W.;Lu Y.-C.;Cheng T.-S.;Lai P.-F.;Tsai C.-H.;Hsu T.-W.;Lin H.-Y.;Shyu H.-Y.;Wu S.-R.;Lin H.-H.;Hsiao P.-W.;Chung-Hsin Chen;Huang H.-P.;Lee M.-S.; Ko C.-J.; Lan S.-W.; Lu Y.-C.; Cheng T.-S.; Lai P.-F.; Tsai C.-H.; Hsu T.-W.; Lin H.-Y.; Shyu H.-Y.; Wu S.-R.; Lin H.-H.; Hsiao P.-W.; CHUNG-HSIN CHEN; Huang H.-P.; Lee M.-S. |
| 臺大學術典藏 |
2021-01-26T03:36:42Z |
Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells (Scientific Reports, (2017), 7, 1, (15101), 10.1038/s41598-017-15415-4)
|
Wu S.-R.; Teng C.-H.; Tu Y.-T.; Ko C.-J.; Cheng T.-S.; Lan S.-W.; Lin H.-Y.; Lin H.-H.; Tu H.-F.; Hsiao P.-W.; Huang H.-P.; CHUNG-HSIN CHEN; Lee M.-S. |
| 臺大學術典藏 |
2021-01-19T12:08:32Z |
Interpretable Neural Network to Model and to Reduce Self-Heating of FinFET Circuitry
|
Chung, Chia Che; Lin, Hsin Cheng; Lin, H. H.; Wan, W. K.; Yang, M. T.; CHEN-WUING LIU |
| 臺大學術典藏 |
2021-01-12T12:49:15Z |
Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma
|
SHANG-YI HUANG; Chen B.-B.; Lu H.-Y.; Lin H.-H.; Wei S.-Y.; Hsu S.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:09Z |
The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy
|
Lin H.-H.; Hwang S.-M.; Wu S.-J.; Hsu L.-F.; Liao Y.-H.; Sheen Y.-S.; Chuang W.-H.; SHANG-YI HUANG |
| 臺大學術典藏 |
2021-01-12T12:49:07Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
SHANG-YI HUANG; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Hou H.-A.; Chou W.-C.; Chou S.-C.; Hsu S.-C.; Ko B.-S.; Lu H.-Y.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:06Z |
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
|
Li C.-C.; Lin C.-W.; Lin H.-H.; SHANG-YI HUANG; Yao M.; Tang J.-L.; Hou H.-A.; Tsay W.; Chou S.-J.; Cheng C.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-08T01:57:16Z |
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
|
Yu C.-J.; Ko J.-C.; MENG-RUI LEE; Huang Y.-P.; Kuo Y.-T.; Luo C.-H.; Shih Y.-J.; Shu C.-C.; Wang J.-Y.; Lin H.-H. |
| 臺大學術典藏 |
2021-01-07T06:09:25Z |
The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus
|
PING-ING LEE; Huang L.-M.; Hsu H.-Y.; Chang M.-H.; Chang M.-H.;Hsu H.-Y.;Huang L.-M.;Ping-Ing Lee;Lin H.-H.;Lee C.-Y.; Lin H.-H.; Lee C.-Y. |
| 臺大學術典藏 |
2021-01-07T06:09:14Z |
Early acquisition of TT virus in infants: Possible minor role of maternal transmission
|
Lin H.-H.;Kao J.-H.;Ping-Ing Lee;Chen D.-S.; Lin H.-H.; Kao J.-H.; PING-ING LEE; Chen D.-S. |
| 臺大學術典藏 |
2021-01-06T08:23:26Z |
Tai Chi Chuan Exercise Improves Lung Function and Asthma Control through Immune Regulation in Childhood Asthma
|
Chiang B.-L.; Lin H.-H.; Liao P.-C.; Liao P.-C.;Lin H.-H.;Chiang B.-L.;Lee J.-H.;Yu H.-H.;Lin Y.-T.;Yao-Hsu Yang;Li P.-Y.;Wang L.-C.;Sun W.-Z.; Lee J.-H.; Yu H.-H.; Lin Y.-T.; YAO-HSU YANG; Li P.-Y.; Wang L.-C.; Sun W.-Z. |
| 臺大學術典藏 |
2021-01-06T03:58:33Z |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Huang S.-Y.; Lin C.-W.; Lin H.-H.; Yao M.; JIH-LUH TANG; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:29Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Huang S.-Y.; Lin H.-H.; Yao M.; JIH-LUH TANG; Wu S.-J.; Hou H.-A.; Chou W.-C.; Chou S.-C.; Hsu S.-C.; Ko B.-S.; Lu H.-Y.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:28Z |
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
|
Huang S.-Y.; Lin H.-H.; Lin C.-W.; Li C.-C.; Yao M.; JIH-LUH TANG; Hou H.-A.; Tsay W.; Chou S.-J.; Cheng C.-L.; Tien H.-F. |
